143 related articles for article (PubMed ID: 34739556)
1. Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes.
Watanabe S; Hidenori U; Hashimoto S; Riko S; Aizawa T; Tsugawa K; Imaizumi T; Tanaka H
J Membr Biol; 2022 Feb; 255(1):117-122. PubMed ID: 34739556
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.
Ahmad A; Mitrofanova A; Bielawski J; Yang Y; Marples B; Fornoni A; Zeidan YH
FASEB J; 2017 Feb; 31(2):771-780. PubMed ID: 27836988
[TBL] [Abstract][Full Text] [Related]
3. SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.
Mitrofanova A; Mallela SK; Ducasa GM; Yoo TH; Rosenfeld-Gur E; Zelnik ID; Molina J; Varona Santos J; Ge M; Sloan A; Kim JJ; Pedigo C; Bryn J; Volosenco I; Faul C; Zeidan YH; Garcia Hernandez C; Mendez AJ; Leibiger I; Burke GW; Futerman AH; Barisoni L; Ishimoto Y; Inagi R; Merscher S; Fornoni A
Nat Commun; 2019 Jun; 10(1):2692. PubMed ID: 31217420
[TBL] [Abstract][Full Text] [Related]
4. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
5. SMPDL3b modulates radiation-induced DNA damage response in renal podocytes.
Francis M; Ahmad A; Bodgi L; Azzam P; Youssef T; Abou Daher A; Eid AA; Fornoni A; Pollack A; Marples B; Zeidan YH
FASEB J; 2022 Oct; 36(10):e22545. PubMed ID: 36094323
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.
Mallela SK; Mitrofanova A; Merscher S; Fornoni A
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158517. PubMed ID: 31487557
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 via Toll-Like Receptor 3 Signaling Attenuates the Expression of Proinflammatory Chemokines in Human Podocytes.
Umetsu H; Watanabe S; Imaizumi T; Aizawa T; Tsugawa K; Kawaguchi S; Seya K; Matsumiya T; Tanaka H
Kidney Blood Press Res; 2021; 46(2):207-218. PubMed ID: 33827102
[TBL] [Abstract][Full Text] [Related]
9. Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.
Merscher S; Fornoni A
Front Endocrinol (Lausanne); 2014; 5():127. PubMed ID: 25126087
[TBL] [Abstract][Full Text] [Related]
10. Lipid biology of the podocyte--new perspectives offer new opportunities.
Fornoni A; Merscher S; Kopp JB
Nat Rev Nephrol; 2014 Jul; 10(7):379-88. PubMed ID: 24861084
[TBL] [Abstract][Full Text] [Related]
11. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.
Shimada M; Ishimoto T; Lee PY; Lanaspa MA; Rivard CJ; Roncal-Jimenez CA; Wymer DT; Yamabe H; Mathieson PW; Saleem MA; Garin EH; Johnson RJ
Nephrol Dial Transplant; 2012 Jan; 27(1):81-9. PubMed ID: 21617192
[TBL] [Abstract][Full Text] [Related]
13. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
14. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
15. The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity.
Heinz LX; Baumann CL; Köberlin MS; Snijder B; Gawish R; Shui G; Sharif O; Aspalter IM; Müller AC; Kandasamy RK; Breitwieser FP; Pichlmair A; Bruckner M; Rebsamen M; Blüml S; Karonitsch T; Fauster A; Colinge J; Bennett KL; Knapp S; Wenk MR; Superti-Furga G
Cell Rep; 2015 Jun; 11(12):1919-28. PubMed ID: 26095358
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of sphingomyelinase phosphodiesterase acid-like 3b in children with intractable nephrotic syndrome.
Watanabe S; Tsugawa K; Tsuruga K; Imaizumi T; Tanaka H
Pediatr Int; 2017 Oct; 59(10):1112-1115. PubMed ID: 29081073
[TBL] [Abstract][Full Text] [Related]
17. Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B.
Abou Daher A; Francis M; Azzam P; Ahmad A; Eid AA; Fornoni A; Marples B; Zeidan YH
FASEB J; 2020 Jun; 34(6):7915-7926. PubMed ID: 32293077
[TBL] [Abstract][Full Text] [Related]
18. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B.
Liu B; Xiao J; Dong M; Qiu Z; Jin J
Cancer Sci; 2020 Jul; 111(7):2259-2274. PubMed ID: 32391585
[TBL] [Abstract][Full Text] [Related]
19. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.
Li G; Kidd J; Gehr TWB; Li PL
Cell Physiol Biochem; 2021 Apr; 55(S4):13-34. PubMed ID: 33861526
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk Between SMPDL3b and NADPH Oxidases Mediates Radiation-Induced Damage of Renal Podocytes.
Azzam P; Francis M; Youssef T; Mroueh M; Daher AA; Eid AA; Fornoni A; Marples B; Zeidan YH
Front Med (Lausanne); 2021; 8():732528. PubMed ID: 34660640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
